Generics: Global Industry Guide
Pages: 195
Publisher: Datamonitor
Date Published: October 2007
Format: PDF
Price: $995
Overview
Datamonitor’s Generics: Global Industry Guide is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.
Scope of the Report
- Contains an executive summary and data on value, volume and segmentation
- Provides textual analysis of the industry’s prospects, competitive landscape and profiles of the leading companies
- Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).
- Includes a five-year forecast of the industry
Highlights
The global generics market grew by 14.2% in 2006 to reach a value of $92.7 billion.
In 2011, the market is forecast to have a value of $155.7 billion, an increase of 68% since 2006.
The ethical generic segment generates 76.8% of the global market’s aggregate value.
Americas accounts for 41.9% of the global market’s total value
Why you should buy this report
- Spot future trends and developments
- Inform your business decisions
- Add weight to presentations and marketing materials
- Save time carrying out entry-level research
Market Definition
The value of the generics market consists of all sales of generics drugs at ex-manufacturers prices. The market does not include animal healthcare products. Datamonitor defines a generic as a product, which is an officially approved copy of an original product whose patent has expired, marketed either as a brand or using the generic name. This definition excludes multi-source copy products that make up much of markets such as India, Spain and Italy. All currency conversions have been calculated at constant 2006 average exchange rates.
For the purpose of this report the Americas comprises Brazil, Canada, Mexico and the US.
Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.
Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.
The global figure comprises the Americas, Asia-Pacific and Europe.
Table of Contents
CHAPTER 1 Introduction
1.1 What is this report about?
1.2 Who is the target reader?
1.3 How to use this report
1.4 Definitions
CHAPTER 2 Global Generics
2.1 Market Overview
2.2 Market Value
2.3 Market Segmentation I
2.4 Market Segmentation II
2.5 Five Forces Analysis
2.6 Market Forecasts
CHAPTER 3 Generics in Asia-Pacific
3.1 Market Overview
3.2 Market Value
3.3 Market Segmentation I
3.4 Market Segmentation II
3.5 Five Forces Analysis
3.6 Market Forecasts
CHAPTER 4 Generics in Europe
4.1 Market Overview
4.2 Market Value
4.3 Market Segmentation I
4.4 Market Segmentation II
4.5 Five Forces Analysis
4.6 Market Forecasts
4.7 Macroeconomic Indicators
CHAPTER 5 Generics in Belgium
5.1 Market Overview
5.2 Market Value
5.3 Market Segmentation I
5.4 Market Segmentation II
5.5 Five Forces Analysis
5.6 Market Forecasts
5.7 Macroeconomic Indicators
CHAPTER 6 Generics in Canada
6.1 Market Overview
6.2 Market Value
6.3 Market Segmentation I
6.4 Market Segmentation II
6.5 Five Forces Analysis
6.6 Market Forecasts
6.7 Macroeconomic Indicators
CHAPTER 7 Generics in China
7.1 Market Overview
7.2 Market Value
7.3 Market Segmentation I
7.4 Market Segmentation II
7.5 Five Forces Analysis
7.6 Market Forecasts
7.7 Macroeconomic Indicators
CHAPTER 8 Generics in France
8.1 Market Overview
8.2 Market Value
8.3 Market Segmentation I
8.4 Market Segmentation II
8.5 Five Forces Analysis
8.6 Forecasts
8.7 Macroeconomic Indicators
CHAPTER 9 Generics in Germany
9.1 Market Overview
9.2 Market Value
9.3 ket Segmentation I
9.4 Market Segmentation II
9.5 Five Forces analysis
9.6 Market Forecasts
9.7 Macroeconomic Indicators
CHAPTER 10 Generics in Italy
10.1 Market Overview
10.2 Market Value
10.3 Market Segmentation I
10.4 Market Segmentation II
10.5 Five Forces Analysis
10.6 Market Forecasts
10.7 Macroeconomic Indicators
CHAPTER 11 Generics in Japan
11.1 Market Overview
11.2 Market Value
11.3 Market Segmentation I
11.4 Market Segmentation II
11.5 Five Forces Analysis
11.6 Market Forecasts
11.7 Macroeconomic Indicators
CHAPTER 12 Generics in the Netherlands
12.1 Market Overview
12.2 Market Value
12.3 Market Segmentation I
12.4 Market Segmentation II
12.5 Five Forces Analysis
12.6 Market Forecasts
12.7 Macroeconomic Indicators
CHAPTER 13 Generics in Spain
13.1 Market Overview
13.2 Market Value
13.3 Market Segmentation I
13.4 Market Segmentation II
13.5 Five Forces Analysis
13.6 Market Forecasts
13.7 Macroeconomic Indicators
CHAPTER 14 Generics in the United Kingdom
14.1 Market Overview
14.2 Market Value
14.3 Market Segmentation I
14.4 Market Segmentation II
14.5 Five Forces Analysis
14.6 Market Forecasts
14.7 Macroeconomic Indicators
CHAPTER 15 Generics in the United States
15.1 Market Overview
15.2 Market Value
15.3 Market Segmentation I
15.4 Market Segmentation II
15.5 Five forces analysis
15.6 Market Forecasts
15.7 Macroeconomic Indicators
CHAPTER 16 Company Profiles
16.1 Leading Companies
CHAPTER 17 Appendix
List of Tables
Table 1: Global Generics Market Value: $ billion, 2002-2006
Table 2: Global Generics Market Segmentation I: % Share, by Value, 2006
Table 3: Global Generics Market Segmentation II: % Share, by Value, 2006
Table 4: Global Generics Market Value Forecast: $ billion, 2006-2011
Table 5: Asia-Pacific Generics Market Value: $ billion, 2002-2006
Table 6: Asia-Pacific Generics Market Segmentation I: % Share, by Value, 2006
Table 7: Asia-Pacific Generics Market Segmentation II: % Share, by Value, 2006
Table 8: Asia-Pacific Generics Market Value Forecast: $ billion, 2006-2011
Table 9: Europe Generics Market Value: $ billion, 2002-2006
Table 10: Europe Generics Market Segmentation I: % Share, by Value, 2006
Table 11: Europe Generics Market Segmentation II: % Share, by Value, 2006
Table 12: Europe Generics Market Value Forecast: $ billion, 2006-2011
Table 13: Europe Exchange Rate, 2002-2006
Table 14: Belgium Generics Market Value: $ million, 2002-2006
Table 15: Belgium Generics Market Segmentation I: % Share, by Value, 2006
Table 16: Belgium Generics Market Segmentation II: % Share, by Value, 2006
Table 17: Belgium Generics Market Value Forecast: $ million, 2006-2011
Table 18: Belgium Size of Population (million) , 2002-2006
Table 19: Belgium GDP (1995=100), 2002-2006
Table 20: Belgium Exchange Rate, 2002-2006
Table 21: Canada Generics Market Value: $ million, 2002-2006
Table 22: Canada Generics Market Segmentation I: % Share, by Value, 2006
Table 23: Canada Generics Market Segmentation II: % Share, by Value, 2006
Table 24: Canada Generics Market Value Forecast: $ million, 2006-2011
Table 25: Canada Size of Population (million) , 2002-2006
Table 26: Canada GDP (1995=100), 2002-2006
Table 27: Canada Inflation, 2002-2006
Table 28: Canada Exchange Rate, 2002-2006
Table 29: China Generics Market Value: $ billion, 2002-2006
Table 30: China Generics Market Segmentation I: % Share, by Value, 2006
Table 31: China Generics Market Segmentation II: % Share, by Value, 2006
Table 32: China Generics Market Value Forecast: $ billion, 2006-2011
Table 33: China Size of Population (million) , 2002-2006
Table 34: China GDP (1995=100), 2002-2006
Table 35: China Inflation, 2002-2006
Table 36: China Exchange Rate, 2002-2006
Table 37: France Generics Market Value: $ billion, 2002-2006
Table 38: France Generics Market Segmentation I: % Share, by Value, 2006
Table 39: France Generics Market Segmentation II: % Share, by Value, 2006
Table 40: France Generics Market Value Forecast: $ billion, 2006-2011
Table 41: France Size of Population (million) , 2002-2006
Table 42: France GDP (1995=100), 2002-2006
Table 43: France Inflation, 2002-2006
Table 44: France Exchange Rate, 2002-2006
Table 45: Germany Generics Market Value: $ billion, 2002-2006
Table 46: Germany Generics Market Segmentation I: % Share, by Value, 2006
Table 47: Germany Generics Market Segmentation II: % Share, by Value, 2006
Table 48: Germany Generics Market Value Forecast: $ billion, 2006-2011
Table 49: Germany Size of Population (million) , 2002-2006
Table 50: Germany GDP (1995=100), 2002-2006
Table 51: Germany Inflation, 2002-2006
Table 52: Germany Exchange Rate, 2002-2006
Table 53: Italy Generics Market Value: $ million, 2002-2006
Table 54: Italy Generics Market Segmentation I: % Share, by Value, 2006
Table 55: Italy Generics Market Segmentation II: % Share, by Value, 2006
Table 56: Italy Generics Market Value Forecast: $ million, 2006-2011
Table 57: Italy Size of Population (million) , 2002-2006
Table 58: Italy GDP (1995=100), 2002-2006
Table 59: Italy Inflation, 2002-2006
Table 60: Italy Exchange Rate, 2002-2006
Table 61: Japan Generics Market Value: $ billion, 2002-2006
Table 62: Japan Generics Market Segmentation I: % Share, by Value, 2006
Table 63: Japan Generics Market Segmentation II: % Share, by Value, 2006
Table 64: Japan Generics Market Value Forecast: $ billion, 2006-2011
Table 65: Japan Size of Population (million) , 2002-2006
Table 66: Japan GDP (1995=100), 2002-2006
Table 67: Japan Exchange Rate, 2002-2006
Table 68: Netherlands Generics Market Value: $ million, 2002-2006
Table 69: Netherlands Generics Market Segmentation I: % Share, by Value, 2006
Table 70: Netherlands Generics Market Segmentation II: % Share, by Value, 2006
Table 71: Netherlands Generics Market Value Forecast: $ million, 2006-2011
Table 72: Netherlands Size of Population (million) , 2002-2006
Table 73: Netherlands GDP (1995=100), 2002-2006
Table 74: Netherlands Exchange Rate, 2002-2006
Table 75: Spain Generics Market Value: $ million, 2002-2006
Table 76: Spain Generics Market Segmentation I: % Share, by Value, 2006
Table 77: Spain Generics Market Segmentation II: % Share, by Value, 2006
Table 78: Spain Generics Market Value Forecast: $ million, 2006-2011
Table 79: Spain Size of Population (million) , 2002-2006
Table 80: Spain GDP (1995=100), 2002-2006
Table 81: Spain Inflation, 2002-2006
Table 82: Spain Exchange Rate, 2002-2006
Table 83: United Kingdom Generics Market Value: $ billion, 2002-2006
Table 84: United Kingdom Generics Market Segmentation I: % Share, by Value, 2006
Table 85: United Kingdom Generics Market Segmentation II: % Share, by Value, 2006
Table 86: United Kingdom Generics Market Value Forecast: $ billion, 2006-2011
Table 87: United Kingdom Size of Population (million) , 2002-2006
Table 88: United Kingdom GDP (1995=100), 2002-2006
Table 89: United Kingdom Inflation, 2002-2006
Table 90: United Kingdom Exchange Rate, 2002-2006
Table 91: United States Generics Market Value: $ billion, 2002-2006
Table 92: United States Generics Market Segmentation I: % Share, by Value, 2006
Table 93: United States Generics Market Segmentation II: % Share, by Value, 2006
Table 94: United States Generics Market Value Forecast: $ billion, 2006-2011
Table 95: United States Size of Population (million) , 2002-2006
Table 96: United States GDP (1995=100), 2002-2006
Table 97: United States Inflation, 2002-2006
Table 98: Key Facts: Teva Pharmaceutical Industries
Table 99: Key Financials: Teva Pharmaceutical Industries
Table 100: Key Facts: Merck KGaA
Table 101: Key Financials: Merck KGaA
Table 102: Key Facts: Sandoz GmbH
List of Figures
Figure 1: Global Generics Market Value: $ billion, 2002-2006
Figure 2: Global Generics Market Segmentation I: % Share, by Value, 2006
Figure 3: Global Generics Market Segmentation II: % Share, by Value, 2006
Figure 4: Drivers of Buyer Power in the Global Generics Market, 2006
Figure 5: Drivers of Supplier Power in the Global Generics Market, 2006
Figure 6: Factors Influencing the Likelihood of New Entrants in the Global Generics Market, 2006
Figure 7: Factors Influencing the Threat of Substitutes in the Global Generics Market, 2006
Figure 8: Factors Influencing Degree of Rivalry in the Global Generics Market, 2006
Figure 9: Global Generics Market Value Forecast: $ billion, 2006-2011
Figure 10: Asia-Pacific Generics Market Value: $ billion, 2002-2006
Figure 11: Asia-Pacific Generics Market Segmentation I: % Share, by Value, 2006
Figure 12: Asia-Pacific Generics Market Segmentation II: % Share, by Value, 2006
Figure 13: Drivers of Buyer Power in the Generics Market in Asia-Pacific, 2006
Figure 14: Drivers of Supplier Power in the Generics Market in Asia-Pacific, 2006
Figure 15: Factors Influencing the Likelihood of New Entrants in the Generics Market in Asia-Pacific, 2006
Figure 16: Factors Influencing the Threat of Substitutes in the Generics Market in Asia-Pacific, 2006
Figure 17: Factors Influencing Degree of Rivalry in the Generics Market in Asia-Pacific, 2006
Figure 18: Asia-Pacific Generics Market Value Forecast: $ billion, 2006-2011
Figure 19: Europe Generics Market Value: $ billion, 2002-2006
Figure 20: Europe Generics Market Segmentation I: % Share, by Value, 2006
Figure 21: Europe Generics Market Segmentation II: % Share, by Value, 2006
Figure 22: Drivers of Buyer Power in the Generics Market in Europe, 2006
Figure 23: Drivers of Supplier Power in the Generics Market in Europe, 2006
Figure 24: Factors Influencing the Likelihood of New Entrants in the Generics Market in Europe, 2006
Figure 25: Factors Influencing the Threat of Substitutes in the Generics Market in Europe, 2006
Figure 26: Factors Influencing Degree of Rivalry in the Generics Market in Europe, 2006
Figure 27: Europe Generics Market Value Forecast: $ billion, 2006-2011
